RACGAP1 and cancer: Current studies support that RACGAP1 promotes cancers by mediating its downstream oncogenic gene expression in signal pathways, and activating Rho-GTPases instead of inactivating Rho-GTPases, despite being named a Rho-GTPase-activating protein.